Evidence map›Paper›PMID 39148551›Full record

ArticleFrontiers in pharmacology2024

Interaction of

Anutthaman Parthasarathy, Renata Rezende Miranda, T J Bedore, Lizabeth M Watts, Pavan K Mantravadi, Narayan H Wong, Jonathan Chu, Joseph A Adjei, Amisha P Rana, Michael A Savka and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anutthaman ParthasarathySchool of Chemistry and Biosciences, University of Bradford, Bradford, United Kingdom.
Renata Rezende MirandaSchool of Chemistry and Materials Science, Rochester Institute of Technology, Rochester, NY, United States.
T J BedoreThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Lizabeth M WattsThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Pavan K MantravadiAgilent Technologies, Santa Clara, CA, United States.
Narayan H WongThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Jonathan ChuThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Joseph A AdjeiThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Amisha P RanaDepartment of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
Michael A SavkaThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Zackery P BulmanDepartment of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.
Eli J BorregoThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
André O HudsonThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.

Funding

Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistanceR15GM144862 · NIGMS · ROCHESTER INSTITUTE OF TECHNOLOGY · PI HUDSON, ANDRE O · 2021 to 2022
$544k
NIGMS NIH HHS R15 GM144862
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is one of the most alarming global public health challenges of the 21st century. Over 3 million antimicrobial-resistant infections occur in the United States annually, with nearly 50,000 cases being fatal. Innovations in drug discovery methods and platforms are crucial to identify novel antibiotics to combat AMR. We present the isolation and characterization of potentially novel antibiotic lead compounds produced by the cross-feeding of two rhizosphere bacteria,

Indexed as

AcinetobacterAMRantibioticsantimicrobial peptidesbioprospectingExiguobacteriumGNPsMDR

Identifiers

PMID39148551
PMCPMC11324575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.